Free Trial
NASDAQ:MBX

MBX Biosciences (MBX) Stock Price, News & Analysis

MBX Biosciences logo
$16.69 -0.06 (-0.36%)
As of 10/3/2025 04:00 PM Eastern

About MBX Biosciences Stock (NASDAQ:MBX)

Advanced

Key Stats

Today's Range
$16.43
$17.68
50-Day Range
N/A
52-Week Range
$4.81
$27.50
Volume
1.68 million shs
Average Volume
2.57 million shs
Market Capitalization
$560.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

MBX Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

MBX MarketRank™: 

MBX Biosciences scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Book Value per Share Ratio

    MBX Biosciences has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    26.11% of the float of MBX Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    MBX Biosciences has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in MBX Biosciences has recently increased by 10.16%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MBX Biosciences does not currently pay a dividend.

  • Dividend Growth

    MBX Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    26.11% of the float of MBX Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    MBX Biosciences has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in MBX Biosciences has recently increased by 10.16%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MBX Biosciences has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.09 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MBX Biosciences this week, compared to 2 articles on an average week.
  • Search Interest

    28 people have searched for MBX on MarketBeat in the last 30 days. This is an increase of 460% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added MBX Biosciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MBX Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    52.19% of the stock of MBX Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about MBX Biosciences' insider trading history.
Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MBX Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MBX Stock News Headlines

Massive Stock Purchase by MBX Biosciences Director!
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
MBX Biosciences Begins Phase 1 Trial for Obesity Drug
See More Headlines

MBX Stock Analysis - Frequently Asked Questions

MBX Biosciences' stock was trading at $14.33 on January 1st, 2025. Since then, MBX shares have increased by 16.5% and is now trading at $16.69.

MBX Biosciences (MBX) raised $163 million in an initial public offering on Friday, September 13th 2024. The company issued 10,200,000 shares at a price of $16.00 per share.

Shares of MBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
N/A
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MBX
Previous Symbol
NASDAQ:MBX
CIK
1776111
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
2018

Profitability

EPS (Trailing Twelve Months)
($4.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.92 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-31.33%
Return on Assets
-29.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.50
Quick Ratio
19.50

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.70 per share
Price / Book
2.17

Miscellaneous

Outstanding Shares
33,590,000
Free Float
16,061,000
Market Cap
$560.62 million
Optionable
N/A
Beta
N/A

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:MBX) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners